Federated Hermes’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.12M | Buy |
787,522
+684,659
| +666% | +$7.93M | 0.02% | 593 |
|
|
2025
Q1 | $898K | Buy |
+102,863
| New | +$898K | ﹤0.01% | 1136 |
|
|
2024
Q3 | – | Sell |
-7,000
| Closed | -$136K | – | 2166 |
|
|
2024
Q2 | $136K | Buy |
+7,000
| New | +$136K | ﹤0.01% | 1534 |
|
|
2023
Q4 | – | Sell |
-9,045
| Closed | -$373K | – | 2214 |
|
|
2023
Q3 | $373K | Hold |
9,045
| – | – | ﹤0.01% | 1414 |
|
|
2023
Q2 | $505K | Sell |
9,045
-1,586
| -15% | -$88.6K | ﹤0.01% | 1369 |
|
|
2023
Q1 | $593K | Sell |
10,631
-15,147
| -59% | -$845K | ﹤0.01% | 1352 |
|
|
2022
Q4 | $939K | Sell |
25,778
-221,750
| -90% | -$8.08M | ﹤0.01% | 1152 |
|
|
2022
Q3 | $7.05M | Buy |
247,528
+136,295
| +123% | +$3.88M | 0.02% | 608 |
|
|
2022
Q2 | $5.03M | Buy |
111,233
+111,201
| +347,503% | +$5.03M | 0.01% | 681 |
|
|
2022
Q1 | $2K | Buy |
+32
| New | +$2K | ﹤0.01% | 2038 |
|
|
2021
Q1 | – | Sell |
-50,662
| Closed | -$7.17M | – | 2348 |
|
|
2020
Q4 | $7.17M | Buy |
50,662
+40,618
| +404% | +$5.75M | 0.01% | 716 |
|
|
2020
Q3 | $1.25M | Buy |
+10,044
| New | +$1.25M | ﹤0.01% | 1163 |
|